focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
B2h , BHuey lifted that from Bourse as per his post. If you go onto Biosynex FR 0011005933 full news item there. Haven't read AFK this a.m
Because it's rubbish that's why - it's not a 'traders share, it's not the grand old duke of york. On the whole it's down, 70% in the last year, no one is making money from that...
Some days it goes up, others it goes down, as do all shares. It won't be the same people buying and selling, some sellers will be hoping to get in lower, others will be off buying something else or holding their money in cash. Then as it falls it will come to the attention of others and they will buy. Maybe they'll sell for 10%, maybe they'll become long term holders.
Stop imagining that others are making fortunes at your expense, they aren't. I mean they might be making a lot elsewhere, they might be making *less* of a loss here than you but no trader is good enough to continually scalp profits with this sort of price action.
I’ve said it for many, many months and have generally been bashed for it.
BabyHuey, -
What is the source please for your statement that "it's not a full takeover, just Europe, Africa and South America territories".
I find it quite ironical that the americans see the need for a rapid test which theoretically can be performed with the skillset of inserting a cartridge,"rapid" it may be but all pcr tests require similar processes and take time to result.The fact is that this took $21m to develop when our own company already has one AND is owed circa £80m from our "government"!
When will we ever learn to spend this sort of cash? on health?
this wasnt a traders share... think you were wrong!
watch it dip slightly more and then climb back into the 240's and REPEAT
of course all entitled to their opinion, but begining to feel long term PI's not wanted here, hence why they (Nova) dont support sp - ah well LONG term hold now, and back to day job!
#noretirementthisyear sigh lol
Hi. Kaeren hope you well... Been thinking a while about microgen and novacyts structure...... Strange times
Didn't know that , thanks.
also just realised it's not a full takeover, just Europe, Africa and South America territories
Kaeren, good thread over on the Bourse forum
https://www.boursorama.com/bourse/forum/1rPALBIO/detail/460440940/
"What, not his core business?
I remind you that the range of Biosynex is quite wide. For example, they have been selling lice combs for a very long time. There, they are mosquito repellent bracelets. We are not that far!!!
I find this little purchase to be very consistent. They will be able to make stands in pharmacies with all these products."
Ah Baby H that's what they want perhaps , Q's in the pharmacies ...
B2H, there's only 4 directors the 5th is a NED, so Bio have 3 out off 7 on the BoD. Para'Kito takeover looks a good idea for growth, Bio's network of pharmacies is about 15k in France alone, Para'kito had 5k pharmacies and a 7m t/o
Yeah I read about that , looking for partners , no other tests available , we have 605 / 610 ?
7.5 hours to process 30 , we sit currently under an hour for 30 , no comparison , no competition.
They do.... Fungal pathogenesis aspirgilliosis............ future
Perhaps you misunderstand some folks sentiment with regard to Bio. Happy to work on a joint venture , not remotely interested in mosquito spray etc. Mushrooms
sprout very fast Gizzmo and too grow overnight.
Grass still grows in the dark wilson maybe in the morning it will be taller....when i invested in primerdesign i saw a differant path... Not down the camden market.... You got to laugh.. I hope the f offs coming soon..im not embracing the feeling on board.... But understand democracy
15 minute RT-qpcr development in USA
March 17, 2022: https://www.medicaldevice-network.com/news/minute-molecular-fda-eua-sars-cov-2-s-test/
+++++
From 'Instructions for Use':
https://www.fda.gov/media/156979/download
"Proprietary Name DASH SARS-CoV-2/S
Test Common or Usual Name DASH SARS-CoV-2/S
Test Intended Use
The DASH SARS-CoV-2/S Test is a real-time RT-PCR assay intended for the qualitative detection of RNA from SARS-CoV-2 in direct anterior nasal swab specimens from individuals suspected of COVID-19 by their healthcare provider. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform high, moderate, or waived complexity tests. The DASH SARS-CoV-2/S Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation."
Page 4 - The DASH SARS CoV-2/S Test contains sufficient reagents to process 12 specimens or quality control samples.
Oops Tks Larry Family conversation at same time...tks
Hi Wilson, it wasnt linked to theradiag
Biosynex buying another company : parakito.
https://m.zonebourse.com/cours/action/BIOSYNEX-7449168/actualite/BIOSYNEX-SA-OFFRE-FERME-PORTANT-SUR-L-ACHAT-DE-LA-MARQUE-PARAKITO-DE-SES-ACTIFS-ET-DE-SA-PROPRIET-39913599/
Good here gizmo the grass pun was alluding to our quiet period :))
Hi wilson hope you well.... Im not too impressed with biosynex ... Novacyt are better than this i hope.... Grass grows at night measure it after brekky
I couldn't open larrys post so reposting
https://ca.movies.yahoo.com/theradiag-change-composition-board-directors-053000585.html
Chart reveals why we might he struggling to break 240p but we will soon andnget a decent move upwards.
https://twitter.com/thecitymile/status/1509227687310680071?t=noEQhZCLt-7iuYWLwRp3lw&s=19
Tax year started in January for the majority of holders (2/3rds).
This too this evening :
https://www.capital.fr/entreprises-marches/biosynex-rachete-parakito-1432556